Literature DB >> 7514630

Inhibition of T cell activation by the extracellular matrix protein tenascin.

T J Hemesath1, L S Marton, K Stefansson.   

Abstract

Tenascin (TN) is an extracellular matrix protein that is expressed widely in the fetus and sparingly in the adult, but reappears at high levels in certain areas of tissue insult such as tumor matrices and sites of wound healing. We show here that soluble TN inhibits proliferation of human T cells in response to alpha CD3 Ab co-immobilized with the extracellular matrix protein fibronectin (FN). TN also inhibits proliferation driven by alpha CD3/IL-2 or by phorbol ester/IL-2, and it prevents high level induction of IL-2R. The presence of TN in culture medium does not detectably alter the pattern of tyrosine phosphorylation resulting from T cell triggering with alpha CD3, but at later time points prevents the appearance of functional NF-AT1 transcription factor complexes in T cell nuclear extracts. These findings are consistent with the postulated role for TN as a natural antagonist to FN action, and suggest that T cell responses occurring at tissue sites in which TN is expressed could be influenced by its presence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514630

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Inhibition of tyrosine kinases blocks adhesion-induced T-cell coactivation without interfering with T-cell adhesion to endothelial cell-surface ligands.

Authors:  Dawn M Nowlin; Pina M Cardarelli; Lynn Young; Jason Mah; Katherine A Felts; Marian Mastrangelo; Ronald R Cobb
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

2.  Tenascin-C expression in normal, inflamed, and scarred human corneas.

Authors:  H Maseruka; R E Bonshek; A B Tullo
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

3.  Mechanisms of malignant glioma immune resistance and sources of immunosuppression.

Authors:  German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2006

Review 4.  Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.

Authors:  Jaime Fornetti; Holly A Martinson; Courtney B Betts; Traci R Lyons; Sonali Jindal; Qiuchen Guo; Lisa M Coussens; Virginia F Borges; Pepper Schedin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-22       Impact factor: 2.673

5.  Mcs5c: a mammary carcinoma susceptibility locus located in a gene desert that associates with tenascin C expression.

Authors:  Adeline L Veillet; Jill D Haag; Jane L Remfert; Amanda L Meilahn; David J Samuelson; Michael N Gould
Journal:  Cancer Prev Res (Phila)       Date:  2011-01

6.  Differential expression of tenascin in the skin during hapten-induced dermatitis.

Authors:  Y Koyama; K Norose; M Kusubata; S Irie; M Kusakabe
Journal:  Histochem Cell Biol       Date:  1996-09       Impact factor: 4.304

Review 7.  Extracellular matrix proteins, regulators of T-cell functions in healthy and diseased individuals.

Authors:  A Gorski; J W Kupiec-Weglinski
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

Review 8.  Fibroblasts, an inconspicuous but essential player in colon cancer development and progression.

Authors:  Naofumi Mukaida; Soichiro Sasaki
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

9.  Fibrous wound repair associated with biodegradable poly-L/D-lactide copolymer implants: study of the expression of tenascin and cellular fibronectin.

Authors:  R Kontio; A Salo; R Suuronen; C Lindqvist; J H Meurman; I Virtanen
Journal:  J Mater Sci Mater Med       Date:  1998-10       Impact factor: 3.896

10.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.